28/08/2026
我們很榮幸攜手支持「2026年主動健康與老齡化國際論壇」。論壇於2026年8月24日至25日在香港會議展覽中心舉行，以「創新 · 聯動 · 賦能－香港構築全球老齡化應對新樞紐」為主題，匯聚全球的創新者、企業家、投資者、業界領袖及政策制定者，共同推動主動健康，並探討人口老齡化帶來的機遇與挑戰。
展會期間，我們展示了在神經退行性疾病（尤其是阿茲海默症）診斷與治療領域的最新科研創新成果，並與來自科研、學術界、醫療保健和產業界的持份者交流分享，探討合作機會。
在論壇上，江源冰博士發表了題為「生物標誌物創新助力阿茲海默症早期檢測與個人化管理」的主題演講，分享了中心在血液生物標誌物方面的最新進展，以及相關創新血液檢測實現阿茲海默症的早期檢測、風險預測與積極主動的個人化健康管理，並在臨床與社區應用，以回應老齡化社會日益增長的醫療需求。
論壇結束後，我們團隊在中心接待上海市養老服務和老齡產業協會代表團。在參訪期間，葉翠芬教授向代表團分享了中心的研發工作，並就科研成果轉化與落地路徑深入交流，重點探討推動血液生物標誌物檢測的更廣泛應用，擴大實際裨益與影響。
We were honored to support the Proactive Health and Aging International Forum 2026, held at HKCEC on 24-25 Aug 2026, themed “Innovation · Collaboration · Empowerment – Hong Kong Forging a New Global Hub for Ageing Solutions”. The Forum convened innovators, entrepreneurs, investors, industry leaders, and policymakers worldwide to advance proactive health and address the opportunities and challenges of population aging.
At the exhibition, we showcased our latest research innovations in diagnostics and therapeutics for neurodegenerative diseases, particularly Alzheimer’s disease, and engaged with stakeholders across research, academia, healthcare, and industry to exchange insights and explore collaboration opportunities.
On stage, Dr. Yuanbing Jiang delivered a thematic talk, “Biomarker Innovation for Early Detection and Personalized Management of Alzheimer’s Disease”, highlighting our advances in blood-based biomarkers that enable early detection, risk prediction, and proactive, personalized health management in both clinical and community settings—helping address the growing healthcare needs of an aging society.
Following the Forum, we were pleased to host a delegation from the Shanghai Elderly Care Service and Silver Industry Association at our Center. During the visit, Prof. F***y Ip shared our R&D work and discussed translation pathways with the delegation, with a focus on advancing blood-based biomarkers toward broader adoption and greater real-world impact.
